Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

How I diagnose and treat chronic myelomonocytic leukemia.

Haematologica - 1 Jul 2022

Patnaik Mrinal M

Abstract excerpt

Chronic myelomonocytic leukemia (CMML) is a myelodysplastic syndrome/myeloproliferative overlap neoplasm characterized by sustained peripheral blood monocytosis and an inherent risk for transformation to acute myeloid leukemia (15-30% over 3-5 years). While CMML is morphologically classified into CMML-0, 1 and 2 based on peripheral blood and bone marrow promonocyte/blast counts, a more clinically relevant...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Leukemia, Myelomonocytic, Chronic
Share to Leukemia, Myelomonocytic, Juvenile
Share to Mutation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Myelodysplastic-Myeloproliferative Diseases

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 35236051
DOI: 10.3324/haematol.2021.279500
PMCID: PMC9244829

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

How I diagnose and treat chronic myelomonocytic leukemia.PMID 35236051Read ↗

Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and managementSemantic proximity Read ↗

Chronic Myelomonocytic Leukemia: a Genetic and Clinical Update.Semantic proximity Read ↗

Chronic Myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and managementSemantic proximity Read ↗

Chronic myelomonocytic leukemia: 2022 update on diagnosis, risk stratification, and managementSemantic proximity Read ↗

How I investigate chronic myelomonocytic leukemia.Semantic proximity Read ↗

Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management.Semantic proximity Read ↗

Chronic myelomonocytic leukemia: 2013 update on diagnosis, risk stratification, and management.Semantic proximity Read ↗

Novel therapeutic targets for chronic myelomonocytic leukemia.Semantic proximity Read ↗

Chronic myelomonocytic leukemia: molecular pathogenesis and therapeutic innovationsSemantic proximity Read ↗

Chronic myelomonocytic leukaemia: a concise clinical and pathophysiological reviewSemantic proximity Read ↗

Chronic Myelomonocytic Leukemia: Insights into Biology, Prognostic Factors, and Treatment.Semantic proximity Read ↗

[Molecular features of 109 patients with chronic myelomonocytic leukemia in a single center].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.